These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21778132)

  • 21. EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma.
    Shibata T; Chuma M; Kokubu A; Sakamoto M; Hirohashi S
    Hepatology; 2003 Jul; 38(1):178-86. PubMed ID: 12830000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.
    Wang XH; Sun X; Meng XW; Lv ZW; Du YJ; Zhu Y; Chen J; Kong DX; Jin SZ
    Oncol Rep; 2010 Oct; 24(4):1093-9. PubMed ID: 20811694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethyl acetate extract from Jiedu Xiaozheng Yin inhibits the proliferation of human hepatocellular carcinoma cells by suppressing polycomb gene product Bmi1 and Wnt/β-catenin signaling.
    Chen XZ; Cao ZY; Li JN; Hu HX; Zhang YQ; Huang YM; Liu ZZ; Hu D; Liao LM; Du J
    Oncol Rep; 2014 Dec; 32(6):2710-8. PubMed ID: 25333742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effect of berberine and HMQ1611 impairs cell proliferation and migration by regulating Wnt signaling pathway in hepatocellular carcinoma.
    Dai B; Ma Y; Yang T; Fan M; Yu R; Su Q; Wang H; Liu F; Yang C; Zhang Y
    Phytother Res; 2019 Mar; 33(3):745-755. PubMed ID: 30565332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WNT/beta-catenin signaling in liver health and disease.
    Thompson MD; Monga SP
    Hepatology; 2007 May; 45(5):1298-305. PubMed ID: 17464972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.
    Zucman-Rossi J; Benhamouche S; Godard C; Boyault S; Grimber G; Balabaud C; Cunha AS; Bioulac-Sage P; Perret C
    Oncogene; 2007 Feb; 26(5):774-80. PubMed ID: 16964294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular pathogenesis of hepatocellular carcinoma.
    Cornellà H; Alsinet C; Villanueva A
    Alcohol Clin Exp Res; 2011 May; 35(5):821-5. PubMed ID: 21303380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pinworm and TNKS inhibitors, an eccentric duo to derail the oncogenic WNT pathway.
    Ouelaa-Benslama R; Emami S
    Clin Res Hepatol Gastroenterol; 2011 Sep; 35(8-9):534-8. PubMed ID: 21782548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hypoxia in hepatocellular carcinoma].
    Myung SJ; Yoon JH
    Korean J Hepatol; 2007 Mar; 13(1):9-19. PubMed ID: 17380070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammalian target of rapamycin regulates expression of β-catenin in hepatocellular carcinoma.
    Feng Z; Fan X; Jiao Y; Ban K
    Hum Pathol; 2011 May; 42(5):659-68. PubMed ID: 21239045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the Wnt/β-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535.
    Gedaly R; Galuppo R; Daily MF; Shah M; Maynard E; Chen C; Zhang X; Esser KA; Cohen DA; Evers BM; Jiang J; Spear BT
    PLoS One; 2014; 9(6):e99272. PubMed ID: 24940873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.
    Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ
    Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on the role of Wnt/beta-catenin signaling transduction pathway in hepatocellular carcinoma cell line HepG2 and L02 cell line].
    Wang QM; Jia LQ; Zhou HY; Li YS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct; 23(10):926-8. PubMed ID: 17908501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Future treatment option for hepatocellular carcinoma: a focus on brivanib.
    Kudo M
    Dig Dis; 2011; 29(3):316-20. PubMed ID: 21829023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecularly targeted therapy in hepatocellular carcinoma.
    Huynh H
    Biochem Pharmacol; 2010 Sep; 80(5):550-60. PubMed ID: 20371362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing.
    Yau TO; Chan CY; Chan KL; Lee MF; Wong CM; Fan ST; Ng IO
    Oncogene; 2005 Feb; 24(9):1607-14. PubMed ID: 15580286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.
    Lee HH; Uen YH; Tian YF; Sun CS; Sheu MJ; Kuo HT; Koay LB; Lin CY; Tzeng CC; Cheng CJ; Tang LY; Tsai SL; Wang AH
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1562-9. PubMed ID: 19423534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
    Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
    Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted therapy of hepatocellular cancer.
    Wysocki PJ
    Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caudatin inhibits human hepatoma cell growth and metastasis through modulation of the Wnt/β-catenin pathway.
    Luo Y; Sun Z; Li Y; Liu L; Cai X; Li Z
    Oncol Rep; 2013 Dec; 30(6):2923-8. PubMed ID: 24064800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.